BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qu X, Gao H, Zhai J, Sun J, Tao L, Zhang Y, Song Y, Hu T. Astragaloside IV enhances cisplatin chemosensitivity in hepatocellular carcinoma by suppressing MRP2. Eur J Pharm Sci 2020;148:105325. [PMID: 32259679 DOI: 10.1016/j.ejps.2020.105325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao H, Song Y, Ma J, Zhai J, Zhang Y, Qu X. Untargeted metabolomics analysis of omeprazole-enhanced chemosensitivity to cisplatin in mice with non-small cell lung cancer. Chem Biol Interact 2022;360:109933. [PMID: 35447140 DOI: 10.1016/j.cbi.2022.109933] [Reference Citation Analysis]
2 Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Reference Citation Analysis]
3 Gao P, Du X, Liu L, Xu H, Liu M, Guan X, Zhang C. Astragaloside IV Alleviates Tacrolimus-Induced Chronic Nephrotoxicity via p62-Keap1-Nrf2 Pathway. Front Pharmacol 2020;11:610102. [PMID: 33536919 DOI: 10.3389/fphar.2020.610102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Balakrishnan B, Liang Q, Fenix K, Tamang B, Hauben E, Ma L, Zhang W. Combining the Anticancer and Immunomodulatory Effects of Astragalus and Shiitake as an Integrated Therapeutic Approach. Nutrients 2021;13:2564. [PMID: 34444724 DOI: 10.3390/nu13082564] [Reference Citation Analysis]
5 Zhang C, Li L, Hou S, Shi Z, Xu W, Wang Q, He Y, Gong Y, Fang Z, Yang Y. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways. J Ethnopharmacol 2021;279:114350. [PMID: 34157326 DOI: 10.1016/j.jep.2021.114350] [Reference Citation Analysis]
6 Ding L, Li H, Wang Y. Application of Jianpi Xiaoai Recipe Combined with Cisplatin and Adriamycin in the Treatment of Endometrial Cancer and Its Effect on Disease Control Rate. Evid Based Complement Alternat Med 2021;2021:2258183. [PMID: 34621319 DOI: 10.1155/2021/2258183] [Reference Citation Analysis]
7 Adamcakova J, Mokra D. Herbal Compounds in the Treatment of Pulmonary Silicosis. Physiol Res. [DOI: 10.33549/10.33549/physiolres.934817] [Reference Citation Analysis]
8 Adamcakova J, Mokra D. Herbal compounds in the treatment of pulmonary silicosis. Physiol Res 2021;70:S275-87. [PMID: 35099247 DOI: 10.33549/physiolres.934817] [Reference Citation Analysis]